Planned maintenance may cause outages to the Department of Health and Aged Care’s network from 5:15 pm AEDT on 30 November to 10:00 pm AEDT on 1 December 2024. Access to TGA databases such as TBS Portal, ARTG and DAEN may be affected. We apologise for any inconvenience.
(Approval lapsed 4/10/19) Fentanyl 0.05 mg/ml solution for injection 100microgram in 2mL ampoules
Section 19A approved medicine
(Approval lapsed 4/10/19) Fentanyl 0.05 mg/ml solution for injection 100microgram in 2mL ampoules
Section 19A approval holder
Medsurge Healthcare Pty Ltd ABN 92 124 728 892
Phone
1300 788 261
Approved until
Status
Lapsed
Medicines in short supply/unavailable
ASPEN FENTANYL fentanyl (as citrate) 100 microgram/2 mL solution for injection - ARTG 170929
DBL FENTANYL 100 microgram/2mL (as citrate) injection USP ampoule - ARTG 107025
Fentanyl GH Solution for Injection 100 microgram/2 mL ampoule - ARTG 201872
DBL FENTANYL 100 microgram/2mL (as citrate) injection USP ampoule - ARTG 107025
Fentanyl GH Solution for Injection 100 microgram/2 mL ampoule - ARTG 201872
Indication(s)
- Fentanyl Citrate is indicated for analgesic action of short duration during premedication, induction and maintenance of anaesthesia and in the immediate post-operative periods. It may be used as an opioid analgesic supplement in general and regional anaesthesia.
- Fentanyl may be used in combination with neuroleptic agents as an anaesthetic premedication, for the induction of anaesthesia and as an adjunct in the maintenance of general and regional anaesthesia. The state of neurolept analgesia may be converted to neurolept anaesthesia by the concurrent administration of 65% nitrous oxide in oxygen